Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Gains from Investment Securities (2024 - 2025)

Historic Gains from Investment Securities for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q2 2025 value amounting to $158000.0.

  • Connect Biopharma Holdings' Gains from Investment Securities rose 13939.39% to $158000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $124000.0, marking a year-over-year change of. This contributed to the annual value of $111000.0 for FY2024, which is 14663.87% up from last year.
  • Connect Biopharma Holdings' Gains from Investment Securities amounted to $158000.0 in Q2 2025, which was up 13939.39% from -$34000.0 recorded in Q1 2025.
  • Over the past 5 years, Connect Biopharma Holdings' Gains from Investment Securities peaked at $158000.0 during Q2 2025, and registered a low of -$34000.0 during Q1 2025.